Abstract
The finding that splenic atrophy is associated with a high complication rate in colitis has led to a long-term, prospective study of spleen size in inflammatory bowel disease. The spleen has been measured in 116 patients undergoing laparotomy for inflammatory bowel disease —2-80 Crohn's disease and 36 ulcerative colitis—from 1975 to 1985. Small spleen size, of lesser degree than that of classic splenic atrophy, is associated with presurgery disease complications as well as infective problems after surgery. Spleen size was not related to site or extent of disease, or to recurrence, but the wide range of spleen size seen in inflammatory bowel disease, comparable to that seen in malignancy suggests that more sophisticated tests of splenic function might show a closer correlation with disease patterns
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ryan FP, Verrier Jones J, Wright JK, Holdsworth CD. Impaired immunity in patients with inflammatory bowel disease and hyposplenism: the response to intravaenous ø X174. Gut 1981;22:187–9.
Palmer KR, Sherriff SB, Holdsworth CD, Ryan FP. Further experience of hyposplenism in inflammatory bowel disease. Q J Med 1981;50:463–71.
Roberts JG, Chare MJ, Leach KG, Baum M. Spleen size in women with breast cancer. Clin Oncol 1979;5:317–23.
Tootla FS, Gennaro A, Malmud L. Splenomegaly with carcinoma of the colon and rectum. Surg Gynecol Obstet 1979;148:412–4.
Wagstaff J, Phadke K, Adam N, Thatcher N, Crowther D. The “hot spleen” phenomenon in metastatic malignant melanoma—its incidence and relationship with the immune system. Cancer 1982;49:439–44.
Roberts JG, Chare MJ, Fortt RW, Leach KG, Baum M. Tumour histology and spleen size in women with breast cancer. Clin Oncol 1980;6:33–8.
Dunn MA, Goldwein MI. Hypersplenism in advanced breast cancer: report of a patient treated with splenectomy. Cancer 1975;35:1449–52.
Koh HK, Sober AJ, Kopf A et al. Prognosis in stage 1 malignant melanoma: seven-year follow-up study of splenic radiocolloid uptake as predictor of death. J Nucl Med 1984;25:1183–9.
Corazza GR, Gasbarrini G. Defective splenic function and its relation to bowel disease. Clin Gastroenterol 1983;12:651–69.
Lewis SM. The spleen—mysteries solved and unresolved. Clin Haematol 1983;12:363–73.
Rozen P, Flatau E, Schujman E, Gefel A. Variability of splenomegaly in Crohn's disease. Am J Gastroenterol 1977;67:489–93.
Putman C, Hall DA. Asymptomatic regional ileitis manifest as fever, hepatic disease, and splenomegaly: a report of a case. Dis Colon Rectum 1974;17:705–9.
Myers MJ. Spleen imaging. Clin Haematol 1983;12:395–420.
Ingeberg S, Støckel M, Sørensen PJ. Prediction of spleen size by routine radioisotope scintigraphy. Acta Haematol (Basel) 1983; 69:243–8.
DeLand FH. Normal spleen size. Radiology 1970;97:589–92.
Bowdler AJ. Splenomegaly and hypersplenism. Clin Haematol 1983;12:467–88.
Smith WI. Hyposplenism and ulcerative colitis (letter to editor). Lancet 1974;2:588.
Levo Y. Hyposplenism in ulcerative colitis (letter to editor). Lancet 1974;2:1321.
Goodyear MD, Forster DC. Hyposplenism in ulcerative colitis (letter to editor). Lancet 1974;2:658.
Smart RC, Ryan FP, Holdsworth CD, Preston FE. Relationship between splenic size and splenic function. Gut 1978;19:56–9.
Author information
Authors and Affiliations
Additional information
Dr. Jorge Pereira was supported by a fellowship from Rotary International.
About this article
Cite this article
Pereira, J.L.R., Hughes, L.E. & Young, H.L. Spleen size in patients with inflammatory bowel disease. Dis Colon Rectum 30, 403–409 (1987). https://doi.org/10.1007/BF02556485
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02556485